★ Sign in to follow
DR

D Redfern

GB·RNS (LSE)
GlaxoSmithKline plc
Total declarations
81
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€93k

Latest filing published 13 May 2021 for GlaxoSmithKline plc, €312.

Filing timeline

BuySale
D Redfern

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

D Redfern: trading record in brief

All filings by D Redfern on record concern GlaxoSmithKline plc. We count 81 filings; the first trade dates from 14 February 2018 and the latest from 12 May 2021.

Every open-market trade on record is a sale: 1 sale worth €93k. Other entries cover 80 share grants. 2021 to date brings no purchases and 1 sale.

On 13 May 2021 came the latest disclosure, a share grant for €312 in GlaxoSmithKline plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 2 days. The regulation allows three business days to notify a trade (UK MAR). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to D Redfern

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations81 total
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    268 GBP0FCA-NSM
    20 shares@ £13.407London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3974287-7
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    75,859 GBP0FCA-NSM
    5,857.511 shares@ £12.9508London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3944285-8
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    232 GBP0FCA-NSM
    18 shares@ £12.9061London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943193-7
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    8,934 GBP0FCA-NSM
    676 shares@ £13.216London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943052-11
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    499 GBP0FCA-NSM
    38 shares@ £13.1379London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3940402-0
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    1,603 GBP0FCA-NSM
    122 shares@ £13.1367London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3938809-8
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    253 GBP0FCA-NSM
    20 shares@ £12.671London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3908301-7
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    0FCA-NSM
    14,126 sharesN/AISIN GB0009252882FCA-NSM:3897443-10
  • ▼
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    80,600 GBP0FCA-NSM
    6,656 shares@ £12.1093N/AISIN GB0009252882FCA-NSM:3897443-11
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    0FCA-NSM
    43,533 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3882407-9
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    0FCA-NSM
    92,622 sharesN/AISIN GB0009252882FCA-NSM:3879317-10
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    0FCA-NSM
    9,755 sharesN/AISIN GB0009252882FCA-NSM:3878373-10
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    0FCA-NSM
    201,409 sharesN/AISIN GB0009252882FCA-NSM:3878367-11
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    254 GBP0FCA-NSM
    20 shares@ £12.717London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3875131-7
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    8,110 GBP0FCA-NSM
    582 shares@ £13.934London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3851939-11
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    52,628 GBP0FCA-NSM
    3,746.077 shares@ £14.0488London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3850615-8
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    404 GBP0FCA-NSM
    29 shares@ £13.939London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3849212-0
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    1,304 GBP0FCA-NSM
    94 shares@ £13.8719London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3847444-8
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    249 GBP0FCA-NSM
    18 shares@ £13.8428London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3844188-7
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    252 GBP19FCA-NSM
    18 shares@ £14.0272100.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3811317-7
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    263 GBP0FCA-NSM
    18 shares@ £14.6233London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3777599-7
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    7,996 GBP0FCA-NSM
    561 shares@ £14.254London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3748390-11
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    51,943 GBP0FCA-NSM
    3,606.925 shares@ £14.4008London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746934-10
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    230 GBP0FCA-NSM
    16 shares@ £14.3994London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746905-7
  • ◆
    D Redfern
    Chief Strategy OfficerExecutivesGlaxoSmithKline plc
    401 GBP0FCA-NSM
    28 shares@ £14.3236London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746894-0

25 of 81 declarations

Related entities

No related entities found.